GP Series: NYC edition
📅 Tuesday, 28 April 2026
⏰ 6:00 – 9:00 PM
📍 NYC - Maxwell Social
🍸 Drinks & bites provided
🎟 Limited spots – make sure to RSVP!
What actually goes into structuring a venture fund?
This panel goes beyond pitch decks and investment theses to unpack the real mechanics of fund design. From fund size and ticket construction to portfolio concentration, reserves, and pacing, we explore the decisions that quietly determine whether a fund works in practice.
Drawing on firsthand experience from experienced GPs, the discussion will cover how early structural choices differ across sectors, where capital intensity, timelines, and risk profiles demand a different approach.
A candid conversation on what first-time GPs get right, what they underestimate, and how fund design shapes everything that follows.
To kick off the panel discussion, we will have a special keynote delivered by one of our GPs, Fredrik Debong, Founding Partner at Nineteen Twenty-One.
Infra One isn’t just a nicer dashboard on top of old processes. We’re rebuilding fund admin from first principles: fully digital, API-native, and cost-aligned with the way venture funds actually operate. That means faster onboarding, cleaner data, better LP reporting, and radical cost reduction across the lifecycle of a fund.
Maxwell Social is a private members club and events venue. We exist to be a hub for industry, culture, intellectual exchange, and social life in the heart of Tribeca.
Show bio
Leif Danielsen is a General Partner at Acequia Capital (AceCap), a Seattle-based early-stage venture fund with over $400M in assets under management and a 15-year track record spanning 350+ investments across 26 countries. Under his leadership, the firm has backed 24 unicorns with notable exits including Groq (acquired by NVIDIA), IonQ (IPO), Pinterest (IPO), Sana Labs (acquired by Workday), and Onfido (acquired by Entrust).
Leif invests at the intersection of AI infrastructure and the New Industrials, dual-use tech, advanced manufacturing, and reshoring, with a particular edge in hard tech and deep science. His approach centers on accessing early, illegible deal flow through technical depth: visiting facilities, following research and founder referral before capital does, and building conviction in domains most investors haven’t yet discovered.
Show bio
Erica Wenger is the Founding General Partner at Park Rangers Capital, an early-stage venture firm backing “elephant companies” — startups that turn customers into members and build enduring, community-driven value. Her viral essay Elephants, Not Unicorns reached millions and established her as a leading voice rethinking venture capital.
A 3x founder and early operator (employee #2 twice), she brings a rare blend of operating depth, investing acumen, and platform reach. She hosts the Trailblazers podcast and has built an audience of 100K+ across platforms, where she shares perspectives on startups, venture, and storytelling.
Park Rangers Capital is backed by leading impact investors, GPs, and operators from companies like Google, OpenAI, and Anthropic. Erica’s work has been featured in major publications including Fortune, Forbes, and The New York Times, and founders consistently describe her as one of the most thoughtful VCs.
Show bio
Rachel ten Brink is General Partner and Co-Founder of Red Bike Capital, an early-stage venture firm backing startups in Vertical AI, Fintech, and Healthcare & Wellness. Red Bike’s edge is hands-on go-to-market support, helping founders land their first enterprise clients through positioning, pricing strategy, and bespoke connections.
Rachel co-founded Scentbird, the Y Combinator-backed subscription company ranked in the top 2% of YC companies by revenue, scaling it to over 1 million subscribers and 86 enterprise partners. She spent two decades building billion-dollar brands at Procter & Gamble, Estée Lauder, Elizabeth Arden, and L’Oréal, bringing Fortune 500 operating depth, founder experience, and go-to-market expertise to every investment.
She chairs the board of LIT, a nonprofit advancing women in leadership, holds an MBA from Columbia Business School, and speaks regularly at events including AWS Startup Day, Y Combinator Alumni Summit, and Bank of America Data Science Conference.
Show bio
Fredrik Debong is the founder of 1921 Ventures – 1921.vc – a fund dedicated to helping making type 1 diabetes suck less.
As a co-founder of mySugr.com, a leading diabetes management app acquired by Roche, as well as hi.health, a fintech in the health insurances space, Fredrik has a proven track record of leveraging technology to improve healthcare. He also cofounded Pioneers.io, an innovation platform fostering entrepreneurship and startups. In his angel portfolio of over 30 companies, his diabetes investments stick out.
1921 Ventures makes use of the expertise and deep networks of its partners and friends. With decades of experience with the disease, its therapy, technology and ecosystem, Fredrik is deeply committed to advancing the future of the therapy and potential cure through cutting-edge innovation.
Show bio
Isabel has spent the past several years working across investing, community-building, and platform development within the global venture and family office ecosystem. She is a co-founder of Horizons, a curated community of next-generation family office principals and leading founders, through which she has hosted private conversations with exceptional leaders across the investment, geopolitical, and technology landscape. Previously, Isabel founded and exited a UK-based social housing business in 2025. She is now working closely with Allocator One, helping to build the US ecosystem.
